Compass Therapeutics, Inc. · NASDAQ:CMPX
BVF PARTNERS L P/IL reported a 5.10% stake in Compass Therapeutics, Inc. (Schedule 13G)
Event Oct 22, 2025 · Filed Oct 29, 2025
BVF PARTNERS L P/IL reported a 5.10% stake in Compass Therapeutics, Inc., 8,750,000 shares, as a passive investor on Oct 22, 2025. Filed Oct 29, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 8,750,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.70% | 4,673,550 |
| BVF I GP LLC | 2.70% | 4,673,550 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.00% | 3,396,894 |
| BVF II GP LLC | 2.00% | 3,396,894 |
| Biotechnology Value Trading Fund OS LP | 0.30% | 542,486 |
| BVF Partners OS Ltd. | 0.30% | 542,486 |
| BVF GP HOLDINGS LLC | 4.70% | 8,070,444 |
| BVF PARTNERS L P/IL | 5.10% | 8,750,000 |
| BVF INC/IL | 5.10% | 8,750,000 |
| LAMPERT MARK N | 5.10% | 8,750,000 |
Source
Related
- Compass Therapeutics, Inc.
- Bvf Partners L P
- Compass Therapeutics, Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4/A · Lerner Neil · Apr 30, 2026